Cargando…
Advances in risk stratification of bladder cancer to guide personalized medicine
Bladder cancer is a heterogeneous disease that poses unique challenges to the treating clinician. It can be limited to a relatively indolent papillary tumor with low potential for progression beyond this stage to muscle-invasive disease prone to distant metastasis. The former is best treated as cons...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000 Research Limited
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069735/ https://www.ncbi.nlm.nih.gov/pubmed/30109022 http://dx.doi.org/10.12688/f1000research.14903.1 |